| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |